FluLaval Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FDA Approved: Yes (First approved August 16, 2013)
Brand name: FluLaval Quadrivalent
Generic name: influenza virus vaccine, inactivated
Company: GlaxoSmithKline
Treatment for: Influenza Prophylaxis
FluLaval Quadrivalent is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in people aged 6 months and older.
Development timeline for FluLaval Quadrivalent
| Date | Article |
|---|---|
| Nov 18, 2016 | Approval GSK Receives FDA Approval for Expanded Indication for FluLaval Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older |
| Aug 16, 2013 | Approval FDA Approves FluLaval Quadrivalent |
| Oct 5, 2006 | Approval FDA Approves FluLaval for Upcoming Influenza Season |
| Mar 23, 2006 | GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
